長聯科技(301618.SZ):擬投建新型硅基材料及智能噴印設備製造建設項目
格隆匯3月10日丨長聯科技(301618.SZ)公佈,基於公司中長期戰略發展規劃,爲滿足公司未來發展需求,公司擬與東莞市寮步鎮人民政府簽署《東莞長聯新材料科技股份有限公司項目履約監管協議》,擬在廣東省東莞市寮步鎮取得產業發展用地約19.9畝用於投資建設新型硅基材料及智能噴印設備製造建設項目。該項目將建立研發基地、生產基地,旨在打造集創意—研發—工程化—產業化於一體的“先進材料+智能製造設備”的產業基地。本項目投資總額不低於人民幣35,000萬元,公司將以自有或自籌資金方式出資,用於項目的建設和運營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.